ConjuChem explained

ConjuChem Biotechnologies Inc.
Type:	Public (TSX has Delisted this Stock)
Location City:	Montreal, Quebec
Location Country:	Canada
Key People:	Mark Perrin
Industry:	Biotechnology
Products:	Drug Affinity Construct (DAC) and Preformed Conjugate-Drug Affinity Construct (PC-DAC)
Num Employees:	44
Homepage:	www.conjuchem.com

ConjuChem Biotechnologies Inc. is a medical biotechnology company located in Montreal, Quebec, Canada^[1] which is credited with inventing the experimental peptide hormone CJC-1295.^{[2] [3]}

It employs 45 people, 90% of whom are in research and development.

Notes and References

1. Web site: Conjuchem Biotechnologies Inc . Bloomberg Business . 18 June 2015.
2. Teichman. Sam L.. Neale. Ann. Lawrence. Betty. Gagnon. Catherine. Castaigne. Jean-Paul. Frohman. Lawrence A.. Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults. The Journal of Clinical Endocrinology & Metabolism. 91. 3. 2006. 799–805. 0021-972X. 10.1210/jc.2005-1536. 16352683. free.
3. Web site: CJC-1295 or Modified GRF (1-29) . American Science Labs . 9 February 2015 . 18 June 2015 . https://web.archive.org/web/20150618123224/http://americansciencelabs.com/research-center/CJC-1295/ . 18 June 2015 . dead .